Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting
Chad A Bousman, Philip Jaksa, Christos Pantelis
Pharmacogenetics and Genomics | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
Awarded by National Health and Medical Research Council of Australia (NHMRC) Career Development Fellowship
Awarded by NHMRC Senior Principal Research Fellowship
C.B. was supported by a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellowship (ID: 1127700). C.P. was supported by an NHMRC Senior Principal Research Fellowship (ID: 1105825). Over the last 5 years, C.P. has participated on Advisory Boards for Janssen-Cilag, Astra-Zeneca, Lundbeck, and Servier. He has received honoraria for talks presented at educational meetings organized by Astra-Zeneca, Janssen-Cilag, Eli-Lilly, Pfizer, Lundbeck, and Shire. For the remaining authors, there are no conflicts of interest.